Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,751 | 728 | 95.2% |
| Education | $595.08 | 11 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,456 | 156 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $2,193 | 132 | $0 (2024) |
| Janssen Biotech, Inc. | $1,240 | 83 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $890.46 | 46 | $0 (2024) |
| Lilly USA, LLC | $740.59 | 41 | $0 (2024) |
| Amgen Inc. | $693.11 | 40 | $0 (2024) |
| PFIZER INC. | $421.21 | 32 | $0 (2023) |
| UCB, Inc. | $380.70 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $375.19 | 18 | $0 (2024) |
| Genentech USA, Inc. | $359.78 | 23 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,815 | 110 | SUN PHARMACEUTICAL INDUSTRIES INC. ($611.34) |
| 2023 | $1,957 | 112 | Sun Pharmaceutical Industries Inc. ($523.56) |
| 2022 | $1,800 | 105 | ABBVIE INC. ($565.27) |
| 2021 | $1,908 | 127 | SUN PHARMACEUTICAL INDUSTRIES INC. ($504.40) |
| 2020 | $1,104 | 63 | AbbVie Inc. ($352.28) |
| 2019 | $1,119 | 70 | Novartis Pharmaceuticals Corporation ($192.28) |
| 2018 | $1,418 | 92 | AbbVie, Inc. ($238.61) |
| 2017 | $1,225 | 60 | AbbVie, Inc. ($192.78) |
All Payment Transactions
739 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Immunology | ||||||
| 12/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $36.55 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/25/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.82 | General |
| Category: Immunology | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $47.99 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Immunology | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Immunology | ||||||
| 10/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.45 | General |
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Dermatology | ||||||
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,226 | 11,086 | $1.5M | $745,550 |
| 2022 | 22 | 2,160 | 9,134 | $1.1M | $560,596 |
| 2021 | 22 | 2,285 | 9,648 | $1.2M | $612,047 |
| 2020 | 19 | 1,962 | 4,632 | $287,823 | $126,755 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 15 | 5,300 | $1.1M | $581,199 | 52.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 782 | 1,614 | $109,752 | $40,769 | 37.1% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 18 | 419 | $67,713 | $33,933 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 257 | 322 | $42,301 | $18,171 | 43.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 135 | 151 | $24,280 | $10,874 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 121 | $22,566 | $9,563 | 42.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 180 | 233 | $22,396 | $7,553 | 33.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 117 | 127 | $18,304 | $6,897 | 37.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 202 | 256 | $13,037 | $6,197 | 47.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 13 | 21 | $12,305 | $6,125 | 49.8% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 20 | 1,561 | $10,726 | $5,434 | 50.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $8,004 | $3,605 | 45.0% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 13 | 17 | $6,686 | $3,313 | 49.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 122 | 637 | $6,009 | $3,004 | 50.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 20 | $5,126 | $2,458 | 47.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 45 | 51 | $4,165 | $1,996 | 47.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 34 | 48 | $3,445 | $1,783 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,402 | $1,090 | 32.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 22 | 27 | $1,115 | $577.80 | 51.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 53 | $1,080 | $485.76 | 45.0% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 13 | 14 | $543.79 | $281.96 | 51.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 30 | 31 | $992.00 | $240.52 | 24.2% |
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2022 | 12 | 3,500 | $720,165 | $378,738 | 52.6% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 23 | 573 | $93,462 | $47,149 | 50.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 737 | 1,350 | $91,800 | $34,563 | 37.6% |
About Dr. Leigh Ann Beard, M.D
Dr. Leigh Ann Beard, M.D is a Dermatopathology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033189295.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leigh Ann Beard, M.D has received a total of $12,346 in payments from pharmaceutical and medical device companies, with $1,815 received in 2024. These payments were reported across 739 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($11,751).
As a Medicare-enrolled provider, Beard has provided services to 8,633 Medicare beneficiaries, totaling 34,500 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Dermatopathology
- Location Lexington, KY
- Active Since 01/23/2006
- Last Updated 10/20/2021
- Taxonomy Code 207ND0900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033189295
Products in Payments
- ILUMYA (Biological) $1,261
- SKYRIZI (Biological) $1,068
- TREMFYA (Drug) $796.28
- COSENTYX (Biological) $681.04
- TALTZ (Drug) $668.02
- Humira (Biological) $593.45
- HUMIRA (Biological) $559.68
- DUPIXENT (Biological) $521.30
- Ilumya (Biological) $452.71
- EUCRISA (Drug) $400.28
- Enbrel (Biological) $391.85
- Erivedge (Biological) $359.78
- Cimzia (Drug) $305.10
- Otezla (Drug) $301.26
- REMICADE (Biological) $191.43
- Tremfya (Drug) $170.36
- RINVOQ (Biological) $170.31
- Sotyktu (Drug) $155.40
- Odomzo (Drug) $147.80
- ENSTILAR (Drug) $133.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Lexington
Dr. James Wharton, Md, MD
Dermatopathology — Payments: $1.2M
Samuel Pruden, Md, MD
Dermatopathology — Payments: $1,892
Yvana Cespedes, M.d, M.D
Dermatopathology — Payments: $1,250
Sheva Khalafbeigi, Md, MD
Dermatopathology — Payments: $334.42
Valerie Taylor, M.d, M.D
Dermatopathology — Payments: $128.25
Mei-Yu Hsu, Md, MD
Dermatopathology — Payments: $18.42